Conquering Diseases

A Study For Patients With Advanced/Metastatic Her2 Negative Gastric Cancer

Description

Seeking men and women over 18 years old with HER2 negative gastric cancer for a study comparing chemotherapy plus investigational drugs to chemotherapy alone.

Overview

We are studying the effect of the drugs pembrolizumab (pembro), lenvatinib, and chemotherapy, compared to just chemotherapy for the treatment of Advanced/Metastatic HER2 Negative Gastric/Gastroesophageal Junction Adenocarcinoma

What we're hoping for

We hope to determine if the drugs pembrolizumab (pembro) plus lenvatinib plus chemotherapy (chemo) in people with HER2 negative gastric cancer work, are tolerated, and how safe they are, compared to chemotherapy alone.

Additional Information

ClinicalTrials.gov Identifier: NCT04662710

 Principal Investigator

Sowmya  Korapati, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989